The demand for the fast and robust development of manufacturing cell lines is ever growing, with an increasing...
Up To Date
Backgrounds & Stories
The Innovative Medicines Initiative 2 (IMI2) has launched a new Antimicrobial Resistance Accelerator...
Roughly 150 life science professionals met at the 5th Biotech Days to discuss the latest progress in...
Integrating the disparate stages of drug development is the most time and cost-efficient way of turning a...
One of the world’s largest and most controversial mergers in the past few years was sealed in early June....
About 25% of the people who suffer from haemophilia A have no therapeutic options, because their immune system...